Drug | Target | Effect on tumor size | Anticipated effect on TK1 | Anticipated imaging response |
---|---|---|---|---|
Cisplatin | DNA formation | ↓ | ↓ | ↓ |
Cyclophosphamide | DNA formation | ↓ | ↓ | ↓ |
Doxorubicin | DNA formation | ↓ | ↓ | ↓ |
Gemcitabine | DNA formation | ↓ | ↓ | ↓ |
Actinomycin D | DNA polymerase | ↓ | ↓ | ↓ |
Irinotecan | Topoisomerase | ↓ | ↓ | ↓ |
Vincristine | Microtubules | ↓ | ↓ | ↓ |
NVP-LAQ824 | TK synthesis | NC | ↓ | ↓ |
PKI-166 | Epidermal growth factor receptor tyrosine kinase | NC | ↓ | ↓ |
Bevacizumab | Vascular endothelial growth factor | NC | ↓ | ↓ |
Rituximab | B lymphocytes | ↓ | NC | ↓ |
5-Fluorouracil, capecitabine | TS blockers | ↓ | ↑ | ↑, then ↓ |
Methotrexate | Folic acid synthesis | ↓ | ↑ | ↑, then ↓ |
↓ = decreased; NC = no change; ↑ = increased.